Patents Assigned to spRNA GmbH
  • Patent number: 10646576
    Abstract: A composition including an immunostimulating RNA molecule in a dication containing solution wherein the RNA includes a chemical modification which is toxic to cancer or tumor cells. Pharmaceutical compositions incorporate the immunostimulating RNA with tumor cytotoxicity. Methods for treating cancer and tumors use the solution of the immunostimulating RNA with tumor cytotoxicity.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: May 12, 2020
    Assignee: spRNA GmbH
    Inventor: Steve Pascolo
  • Patent number: 9771594
    Abstract: A biologically active RNA-alkali metal-dication formulation, a pharmaceutical composition containing the complexes, and methods of producing the same. The formulation is particularly useful to introduce RNA and an attached cargo into cells allowing its biological intracellular activities: e.g. immunostimulation (immunomodulation), RNA interference or gene expression.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: September 26, 2017
    Assignee: spRNA GmbH
    Inventor: Steve Pascolo